Decorin gene transfer promotes muscle cell differentiation and muscle regeneration

Molecular Therapy

Volumn 15, Issue 9, 2007, Pages 1616-1622

  Li, Yong ^a,b   Li, Juan ^b   Zhu, Jinghong ^a   Sun, Bin ^a   Branca, Maria ^a   Tang, Ying ^a   Foster, William ^a   Xiao, Xiao ^b   Huard, Johnny ^a,b,c  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECORIN; FOLLISTATIN; MYOD PROTEIN; MYOGENIC FACTOR; MYOGENIC FACTOR 5; MYOGENIC FACTOR 6; MYOGENIN; MYOSTATIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN P21; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CLONE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; FEMALE; FIBROSIS; GENETIC TRANSDUCTION; IN VITRO STUDY; IN VIVO GENE TRANSFER; MOUSE; MUSCLE INJURY; MUSCLE REGENERATION; MYOBLAST; MYOTUBE; NONHUMAN; SKELETAL MUSCLE; UPREGULATION; WOUND HEALING;

ADENOVIRIDAE; ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE; CELL TRANSPLANTATION; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBROSIS; FOLLISTATIN; GENE THERAPY; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MICE, SCID; MODELS, BIOLOGICAL; MUSCLE FIBERS; MUSCLE, SKELETAL; MYOBLASTS; PROTEOGLYCANS; REGENERATION; TRANS-ACTIVATORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 34548072165     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/sj.mt.6300250     Document Type: Article

References (49)

1. Hocking, AM, Shinomura, T and McQuillan, DJ (1998). Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol 17: 1-19.
2. Sottile, J, Hocking, DC and Swiatek, PJ (1998). Fibronectin matrix assembly enhances adhesion-dependent cell growth. J Cell Sci 111: 2933-2943.
3. Giri, SN, Hyde, DM, Braun, RK, Gaarde, W, Harper, JR and Pierschbacher, MD (1997). Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis. Biochem Pharmacol 54: 1205-1216.
4. Noble, NA, Harper, JR and Border, WA (1992). In vivo interactions of TGF-beta and extracellular matrix. Prog Growth Factor Res 4 369-382.
5. Stander, M, Naumann, U, Dumitrescu, L, Heneka, M, Loschmann, P. Gulbins, E et al. (1998). Decorin gene transfer-mediated suppression of TGF-beta synthesis abrogates experimental malignant glioma growth in vivo. Gene Ther 5: 1187-1194.
6. Nishimura, T, Futami, E, Taneichi, A, Mori, T and Hattori, A (2002). Decorin expression during development of bovine skeletal muscle and its role in morphogenesis of the intramuscular connective tissue. Cells Tissues Organs 171: 199-214.
7. Brandan, E, Fuentes, ME and Andrade, W (1991). The proteoglycan decorin is synthesized and secreted by differentiated myotubes. Eur J Cell Biol 55: 209-216.
8. Casar, JC, McKechnie, BA, Fallon, JR, Young, MF and Brandan, E (2004). Transient up-regulation of biglycan during skeletal muscle regeneration: delayed fiber growth along with decorin increase in biglycan-deficient mice. Dev Biol 268: 358-371.
9. Yoshida, N, Yoshida, S, Koishi, K, Masuda, K and Nabeshima, Y (1998). Cell heterogeneity upon myogenic differentiation: Down-regulation of MyoD and Myf-5 generates 'reserve cells'. J Cell Sci 111: 769-779.
10. Li, Y, Cummins, J and Huard, J (2001). Muscle injury and repair. Curr Opin Orthop 12: 409-415.
11. Fukushima, K, Badlani, N, Usas, A, Riano, F, Fu, F and Huard, J (2001). The use of an antifibrosis agent to improve muscle recovery after laceration. Am J Sports Med 29: 394-402.
12. Harper, JR, Spiro, RC, Gaarde, WA, Tamura, RN, Pierschbacher, MD, Noble, NA et al. (1994). Role of transforming growth factor beta and decorin in controlling fibrosis. Methods Enzymol 245: 241-254.
13. Isaka, Y, Brees, DK, Ikegaya, K, Kaneda, Y. Imai, E, Noble, NA et al. (1996). Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 2: 418-423.
14. Kobayashi, E, Sasamura, H, Mifune, M, Shimizu-Hirota, R, Kuroda, M, Hayashi, M et al. (2003). Hepatocyte growth factor regulates proteoglycan synthesis in interstitial fibroblasts. Kidney Int 64: 1179-1188.
15. Csordas, G, Santra, M, Reed, CC, Eichstetter, I, McQuillan, DJ, Gross, D et al. (2000). Sustained down-regulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo. J Biol Chem 275: 32879-32887.
16. Iozzo, RV, Moscatello, DK, McQuillan, DJ and Eichstetter, I (1999). Decorin is a biological ligand for the epidermal growth factor receptor. J Biol Chem 274: 4489-4492.
17. Schonherr, E, Sunderkotter, C, Iozzo, RV and Schaefer, L (2005). Decorin, a novel player in the insulin-like growth factor system. J Biol Chem 280: 15767-15772.
18. De Luca, A, Santra, M, Baldi, A, Giordano, A and Iozzo, RV (1996). Decorin-induced growth suppression is associated with up-regulation of p2l, an inhibitor of cyclin-dependent kinases. J Biol Chem 271 18961-18965.
19. Schonherr, E, Levkau, B, Schaefer, L, Kresse, H and Walsh, K (2001 ). Decorin-mediated signal transduction in endothelial cells. Involvement of Akt/protein kinase B in up-regulation of p2l (WAF1/CIP1) but not p27(KIP1). J Biol Chem 276: 40687-40692.
20. Budasz-Rwiderska, M, Jank, M and Motyl, T (2005). Transforming growth factor-betal upregulates myostatin expression in mouse C2C12 myoblasts. J Physiol Phormacol 56 (suppl. 3): 195-214.
21. Amthor, H, Nicholas, G, McKinnell, I, Kemp, CF, Sharma, M, Kambadur, R et al. (2004). Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis. Dev Biol 270: 19-30.
22. Lee, SJ and McPherron, AC (2001). Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 98: 9306-9311.
23. Miura, T, Kishioka, Y, Wakamatsu, J, Hattori, A, Hennebry, A, Berry, CJ et al (2006). Decorin binds myostatin and modulates its activity to muscle cells. Biochem Biophys Res Commun 340: 675-680.
24. McCroskery, S, Thomas, M, Platt, L, Hennebry, A, Nishimura, T, McLeay, L et al. (2005). Improved muscle healing through enhanced regeneration and reduced fibrosis in myostatin-null mice. J Cell Sci 118: 3531-3541.
25. Duguez, S, Feasson, L, Denis, C and Freyssenet, D (2002). Mitochondrial biogenesis during skeletal muscle regeneration. Am J Physiol Endocrinol Metab 282: E802-E809.
26. Lin, J, Wu, H, Tarr, PT, Zhang, CY, Wu, Z, Boss, O et al. (2002). Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418: 797-801.
27. Li, Y, Foster, W, Deasy, BM, Chan, Y. Prisk, V, Tang, Y et al. (2004). Transforming Growth Factor-betal Induces the Differentiation of Myogenic Cells into Fibrotic Cells in Injured Skeletal Muscle: A Key Event in Muscle Fibrogenesis. Am J Pathol 164: 1007-1019.
28. Li, Y and Huard, J (2002). Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol 161: 895-907.
29. Chan, YS, Li, Y, Foster, W, Fu, FH and Huard, J (2005). The use of suramin, an antifibrotic agent, to improve muscle recovery after strain injury. Am J Sports Med 33: 43-51.
30. Chan, YS, Li, Y, Foster, W, Horaguchi, T, Somogyi, G, Fu, FH et al. (2003). Antifibrotic effects of suramin in injured skeletal muscle after laceration. J Appl Physiol 95: 771-780.
31. Sato, K, Li, Y, Foster, W, Fukushima, K, Badlani, N, Adachi, N et al. (2003). Improvement of muscle healing through enhancement of muscle regeneration and prevention of fibrosis. Muscle Nerve 28: 365-372.
32. Huard, J, Li, Y and Fu, FH (2002). Muscle injuries and repair: Current trends in research. J Bone Joint Surg Am 84-A: 822-832.
33. Engert, JC, Berglund, EB and Rosenthal, N (1996). Proliferation precedes differentiation in IGF-1-stimulated myogenesis. J Cell Biol 135 431-440.
34. McFarland, DC, Pesall, JE and Gilkerson, KK (1993). The influence of growth factors on turkey embryonic myoblasts and satellite cells in vitro. Gen Comp Endocrinol 89: 415-424.
35. Sheehan, SM and Allen, RE (1999). Skeletal muscle satellite cell proliferation in response to members of the fibroblast growth factor family and hepatocyte growth factor. J Cell Physiol 181: 499-506.
36. Tatsumi, R Anderson, JE, Nevoret, CJ, Halevy, O and Allen, RE (1998). HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells. Dev Biol 194: 114-128.
37. Beauchamp, JR, Heslop, L, Yu, DS, Tajbakhsh, S, Kelly, RG, Wernig, A et al. (2000). Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J Cell Biol 151: 1221-1234.
38. Chambers, RL and McDermott, JC (1996). Molecular basis of skeletal muscle regeneration. Can J Appl Physiol 21: 155-184.
39. Bischoff, R (1994). The satellite cell and muscle regeneration. In Engel, AG and Franzini-Armstrong, C (eds). Myology: Basic and Clinical. McGraw-Hill, New York. pp. 97-118.
40. Shen, W, Li, Y, Tang, Y, Cummins, J and Huard, J (2005). NS-398, a cyclooxygenase-2-specific inhibitor, delays skeletal muscle healing by decreasing regeneration and promoting fibrosis. Am J Pathol 167 1105-1117.
41. Jarvinen, TA, Jarvinen, TL, Kaariainen, M, Kalimo, H and Jarvinen, M (2005). Muscle injuries: Biology and treatment. Am J Sports Med 33: 745-764.
42. Branton, MH and Kopp, JB (1999). TGF-β and fibrosis. Microbes Infect 1: 1349-1365.
43. Franklin, TJ (1997). Therapeutic approaches to organ fibrosis. Int J Biochem Cell Biol 29: 79-89.
44. Zhao, J, Sime, PJ, Bringas, F, Gauldie, J and Warburton, D (1999). Adenovirus-mediated decorin gene transfer prevents TGF-beta-induced inhibition of lung morphogenesis. Am J Physiol 277: L412-L422.
45. Gong, R, Rifai, A, Tolbert, EM, Centracchio, JN and Dworkin, LD (2003). Hepatocyte growth factor modulates matrix metalloproteinases and plasminogen activator/plasmin proteolytic pathways in progressive renal interstitial fibrosis. J Am Soc Nephrol 14: 3047-3060.
46. Taniyama, Y. Morishita, R, Nakagami, H, Moriguchi, A, Sakonjo, H, Shokei, K et al. (2000). Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters. Circulation 102: 246-252.
47. Yang, J, Dai, C and Liu, Y (2002). Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice. J Am Soc Nephrol 13: 2464-2477.
48. Norrbom, J, Sundberg, CJ, Ameln, H, Kraus, WE, Jansson, E and Gustafsson, T (2004). PGC-1alpha mRNA expression is influenced by metabolic perturbation in exercising human skeletal muscle. J Appl Physiol 96: 189-194.
49. Xiao, X, Li, J and Samulski, RJ (1998). Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 72: 2224-2232.